Capital Fund Management S.A. Tg Therapeutics, Inc. Put Options Transaction History

Capital Fund Management S.A.

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$13.02 - $21.3 $2.27 Million - $3.71 Million	-174,200 Reduced 73.78%	61,900 $941,000
Q4 2023 Feb 14, 2024	BUY	$6.68 - $18.81 $846,356 - $2.38 Million	126,700 Added 115.81%	236,100 $4.03 Million
Q3 2023 Nov 14, 2023	SELL	$8.36 - $26.5 $621,148 - $1.97 Million	-74,300 Reduced 40.45%	109,400 $914,000
Q2 2023 Aug 14, 2023	BUY	$15.48 - $35.0 $636,228 - $1.44 Million	41,100 Added 28.82%	183,700 $4.56 Million
Q1 2023 May 15, 2023	BUY	$10.23 - $19.34 $1.46 Million - $2.76 Million	142,600 New	142,600 $2.14 Million

Q4 2021 Feb 10, 2022	SELL	$15.2 - $35.51 $399,760 - $933,913	-26,300 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$21.78 - $40.45 $572,814 - $1.06 Million	26,300 New	26,300 $875,000

272

88.1M

2.72M

1.74M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $3.05B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.